Amaero’s Scheme Amendment Raises Questions on Option Holder Value and Timing
Amaero Ltd has amended its scheme implementation deed, revising the consideration offered to option holders as it progresses with its re-domiciliation from Australia to the US. Key milestones for the transition are scheduled through mid-2026.
- Amendment to Scheme Implementation Deed changes option holder consideration
- Option holders to receive unlisted options in new US holding company
- Scheme Booklet distribution expected early May 2026
- Shareholder and option holder meetings scheduled for early June 2026
- Trading of new US HoldCo securities to commence mid to late June 2026
Background to the Re-domiciliation
Amaero Ltd (ASX:3DA), a manufacturer specialising in advanced materials and additive manufacturing, is advancing its plan to re-domicile from Australia to the United States. This strategic move involves transferring its corporate structure to a newly formed Delaware corporation, Amaero US HoldCo, reflecting its operational headquarters in Tennessee and aligning with its core markets.
Key Amendment to Option Holder Consideration
On 23 March 2026, Amaero executed an amendment to its previously announced Scheme Implementation Deed. The critical change affects how option holders will be compensated under the Option Scheme. Instead of previous terms, option holders will now receive one unlisted option in Amaero US HoldCo for each option held in Amaero Ltd. Each unlisted option grants the right to acquire a CHESS Depositary Interest (CDI) representing 1/40th of a share of common stock in the US entity.
This adjustment clarifies the conversion ratio and the nature of securities option holders will receive, aligning their interests with the new corporate structure while maintaining exposure to the company’s future growth.
Timetable and Next Steps
The company has outlined an indicative timetable for the scheme process. A detailed Scheme Booklet will be distributed to shareholders and option holders in early May 2026, providing comprehensive information on the re-domiciliation and the associated schemes of arrangement.
Following this, shareholder and option holder meetings are scheduled for early June, alongside a second court hearing to approve the schemes. If approved, the schemes are expected to become effective by mid-June, coinciding with the last day of trading for Amaero shares on the ASX.
Subsequently, trading of Amaero US HoldCo CDIs will commence on the ASX on a deferred settlement basis, transitioning to normal settlement by late June. This phased approach aims to ensure a smooth transition for investors and maintain market liquidity.
Strategic Implications
The re-domiciliation reflects Amaero’s strategic focus on the US market, where its manufacturing and corporate headquarters are located. The move is expected to streamline regulatory compliance and better position the company within its key defence, aerospace, and medical industry sectors.
For investors, the amendment to the option scheme provides clearer terms and maintains value alignment through the new US-listed securities. However, the timetable remains subject to court approvals and other conditions, which could affect the pace of the transition.
Bottom Line?
Amaero’s re-domiciliation progresses with clearer option holder terms, setting the stage for a pivotal mid-year corporate transition.
Questions in the middle?
- How will the market value Amaero US HoldCo CDIs compared to current Amaero shares?
- What are the potential regulatory hurdles that could delay the scheme’s court approval?
- How will the re-domiciliation impact Amaero’s access to US government contracts and funding?